Lanthio Pharma is a biopharmaceutical company focused on discovering and developing Lantipeptides, a new class of peptides with high target selectivity and improved "drug-like" properties.
Peptide therapeutics are an increasingly important class of drugs. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk. Importantly they can be applied to targets, where small molecules or antibody-based drugs are not an option.
PO Box 719, 9700 AS Groningen
Rozenburglaan 13 B, 9727 DL Groningen
T: +31 50 30 50 240